IRCT2017013132326N1
Completed
未知
Assessment the efficacy of augmentation Flavonoid Quercetin to risperidon in treatment of autism spectrum disorders
Vice Chancellor for Research of Mashhad University of Medical Sciences0 sites70 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Autism Spectrum Disorders.
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The inclusion criteria: Of all patients with ASD, ranging in age from 3to 12years; Parent's Consent; No obvious organic disease; The lack of other psychiatric disorders; Not taking other psychoactive medications other than risperidone; IQ higher than 50 on the basis of Weiland test.
- •The exclusion criteria: In the absence of cooperation of parents after inclusion; the risk of any side effect or another disease that cause a problem in results.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Intervention study on the effect of a flavanol-rich cocoa powder on postprandial blood pressure, glucose and fat metabolism in type 2 diabetics with stable metabolic controlE11Type 2 diabetes mellitusDRKS00012561Hochschule NiederrheinFachbereich Oecotrophologie12
Completed
Not Applicable
Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients resistant to an anticholinergic agentJPRN-UMIN000009999Department of Urology, University of the Ryukyus50
Completed
Not Applicable
Intervention study on regular intake of a flavanol-rich cocoa powder on blood pressure, glucose and fat metabolism in type-2 diabetics with stable metabolic controlE11Type 2 diabetes mellitusDRKS00011007Hochschule Niederrhein, Fachbereich Oecotrophologie42
Recruiting
Phase 4
Does giving higher dose of folic acid improve intolerance associated with methotrexate in patients of Rheumatoid arthritisHealth Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecifiedCTRI/2023/04/051346PGIMER, Chandigarh
Recruiting
Phase 1
Evaluation of the prophilatic effects of the flavonoid Hesperidin Methyl Chalcone on Delayed Onset Muscle Soreness in humansMyalgiaM62.9RBR-7wvr64kniversidade Norte do Paraná